In this week’s episode of DeviceTalks Weekly, neurosurgeon Adam Arthur, MD, explains why he’s trading surgical scrubs for the chance to help lead Medtronic’s Neurovascular business as its new chief medical officer. Dr. Arthur joins Host Tom Salemi to discuss how neurosurgery is reaching more patients today—and what it must do to expand its impact in the years ahead.

Before the keynote interview, Managing Editor Kayleen Brown speaks with Brittany Mai of Confluent Medical Technologies about the future of neuro and minimally invasive surgery. Thank you to Confluent for sponsoring this week’s episode. Learn more at ConfluentMedical.com.

At the top of the show, MassDevice Editor Chris Newmarker talks with Wayne Paterson, CEO of Anteris Technologies, about the company’s new agreement with Medtronic and what it means for the future of TAVR.

Thank you for listening to DeviceTalks Weekly!

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

• (00:03:38) - Chris Newmarker interviews Wayne Paterson, CEO of Anteris Technologies
• (00:06:10) - This is not your Father’s TAVR
• (00:08:00) - Terms of the Medtronic investment
• (00:25:30) - Kayleen Brown sits down with Brittany Mai of Confluent Medical
• (00:29:50) - How is minimally invasive technology changing?
• (00:31:28) - Keynote conversation – Adam Arthur, MD, new chief medical officer for Medtronic Neurovascular
• (00:35:30) - What makes a good neurosurgeon?
• (00:39:01) - Choosing impact over intimacy
• (00:44:50) - What do patients fear more than death?
• (00:49:45) - More focus needed on Women’s neurological health including chronic refractory migraine

In this episode of DeviceTalks Weekly, Host Tom Salemi interviews Jupiter Endovascular CEO Carl St. Bernard about the “soft” design of the company's TFX technology, designed to simplify the complicated procedure of clearing cardiovascular blockages, including pulmonary artery embolisms. Jupiter is recording fundraising and clinical trials wins. St. Bernard shares what’s next.

In this week’s FOMO, Kayleen Brown interviews Javier Olea, Life Science Segment Director at Averna about test and measurement in medical device manufacturing. Visit http://Averna.com to learn more.

We open the episode with this week’s Newsmakers compiled by MassDevice Editor Chris Newmarker – Merge, OpenAI, Abbott, Johnson & Johnson MedTech, Boston Scientific, Medtronic, Anteris Technologies.

To register for our upcoming Cardiac Innovation series go here: https://event.on24.com/wcc/r/5203526/B4EE367D76F7ECCAC132665B50E61A7C/5516160?partnerref=Podcast

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

• (00:06:00) - #5 - OpenAI invests in Sam Altman’s Merge Labs BCI startup
• (00:08:30) - #4 - Abbott picks up CE mark for TactiFlex dual-energy ablation catheter
• (00:11:27) - #3 - Johnson & Johnson MedTech sales up 7.5% in Q4
• (00:13:24) - #2 - Boston Scientific has a potentially serious Axios stent recall
• (00:15:00) - #1 - Medtronic to invest up to $90M in Anteris Technologies
• (00:21:20) - FOMO - Advancing Test & Measurement Strategies in MedTech Manufacturing with Javier Olea of Averna
• (00:32:50) - Keynote Interview: Carl St. Bernard, CEO, Jupiter Endovascular

In this episode of DeviceTalks Weekly, Rob Binney, CEO of ShiraTronics, explains how the neurostimulation device is working to provide some relief for people suffering from chronic migraines. Binney’s career started in pharma, but he’s built a MedTech career at significant companies including AccessClosure, Intersect ENT before taking his first CEO role at Alydia Health.

In our FOMO interview, Steven Mickelsen, MD, chief technology officer and founder of Field Medical, details the different challenges in taking on ventricular cardiac arrhythmias vs. atrial fibrillation where he built his monumental success.

Dr. Mickelsen will also share Field Medical’s story at our DeviceTalks Cardiac Innovations Series taking place Feb 3-5. Register at DeviceTalks.com to watch live or on demand.

MassDevice’s Chris Newmarker brings his Newmarker’s Newsmakers – Johnson & Johnson MedTech, Edwards Lifesciences, Distalmotion, Intuitive Surgical, Medtronic, and Boston Scientific.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

• (00:05:12) - Distalmotion secures funding from J&J to support Dexter rollout in ASCs
• (00:06:43) - Edwards gives up on $1.2B JenaValve acquisition
• (00:09:00) - Intuitive says daVinci systems ‘exceeded expectations,’ it wants more
• (00:11:12) - Medtronic has ‘significant firepower’ to boost M&A
• (00:13:08) - All the big news from Boston Scientific
• (00:20:10) - FOMO – Steven Mickelsen, MD, Founder, Field Medical
• (00:27:40) - Keynote Interview, Rob Binney, CEO, ShiraTronics